05.09.2017 • News

EP Approves Rules to Protect Workers From Cancer

(c) andrej pol/Shutterstock
(c) andrej pol/Shutterstock

The European Parliament (EP) has approved new rules to protect workers from carcinogens and mutagens in the workplace, with the aim of saving up to 100,000 lives over the next 50 years. The Employment Committee voted in favour of the legislation by 42 votes to none, with eight abstentions.

Under the proposal, which has already been informally agreed with EU ministers, employers will have to assess the risk of exposure for workers and take preventive measures. The rules include a lower occupational exposure limit (OEL) – a maximum quantity of harmful substances that workers can be exposed to – for chromium VI, vinyl chloride monomer (VCM) and hardwood dust.

The Committee said it hoped this would tackle the primary cause of work-related deaths in the EU, which is cancer. The most common types of occupational cancer are lung cancer, mesothelioma (caused by exposure to asbestos particles) and bladder cancer.  The World Health Organization (WHO) estimates that every tenth lung-cancer death is closely related to workplace risks.

MEPs have also ensured that the Commission will have to assess the possibility of including reprotoxic substances (those that affect sexual function and fertility) by the first quarter of 2019. A recent study showed that more than 1% of workers are exposed to reprotoxic substances, meaning that between two to three million in the EU could be affected.

The EP will put the draft directive to a final vote during an upcoming plenary session in Strasbourg, France.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.